Assistant Professor, Division of Dermatology

Contact Information

VA Puget Sound
Health Care System
Seattle Division
Box 358280
Seattle, WA 98195-8280
Office: 206-764-2305
Fax: 206-764-2689

University of Washington
Box 354697
Seattle, WA 98195-6524
Clinic: 206-598-4067
Fax: 206-598-2267



Return to Faculty Directory

Education and Training

Internal Medicine Internship, Pennsylvania Hospital, 2007 - 2008
Cutaneous Oncology Fellowship, University of Pennsylvania, 2007 - 2008
Dermatology Residency, University of Pennsylvania, 2008 - 2011
Co-Chief Resident, University of Pennsylvania, 2011

Clinical Educational Interests

General Dermatology

Representative Publications

* Gardner JM, Nelson M, Heffernan M.  Chronic cutaneous fusariosis. Arch Dermatol. 2005 Jun;141(6):794-5.

Moulson CL, Go G, Gardner JM, van der Wal AC, Smitt HS, van Hagan JM, Miner JH.  Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy.   Journal of Investigative Dermatology. 2005 Nov;125(5):913-9. 

Moulson CL, Fong LG, Gardner JM, Farber EA, Go G Passariello A, Grange DK, Young SG, Miner JH.  Increased progerin expression associated with unusual LMNA mutation causes severe progeroid syndromes.  Hum Mutat. 2007 Sep;28(9):882-9.

Gao L, Feng Y, Bowers R, Becker-Hapak M, Gardner J, Council L, Linette G, Zhao H, Cornelius LA.  Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis.  Cancer Res. 2006 Aug 15;66(16):7880-8.

Council ML, Gardner JM, Helms C, Liu Y, Cornelius LA, Bowcock AM.  Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients.  Experimental Dermatology. 2008.

Liu Y, Helms, C, Liao W, Zaba LC, Duan S, Gardner J, Wise C, Miner A, Malloy MJ, Pullinger C, Kane J, Saccone S, Worthington J, Bruce I, Kwok P-Y, Menter A, Krueger J, Barton A, Saccone NL, Bowcock AM.  A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 2008 Mar 28;4(3):e1000041.

* Gardner JM, Introcaso CE, Nasta SD, Kim EJ, Vittorio CC, Rook AH.  A novel regimen of vorinostat with interferon gamma for refractory Sezary syndrome.  (Accepted for publication, JAAD, 2009) Introcaso CE, Kim EJ, Gardner J, Junkins-Hopkins JM, Vittorio CC, Rook AH. CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central

* Gardner JM, Evans K, Goldstein S, Kim EJ, Vittorio CC, Rook AH.  Vorinostat for the treatment of bullous pemphigoid in the setting of advanced, refractory cutaneous T cell lymphomaArch Dermatol. 2009:145(9):985-8.

* Council ML, Gardner JM, Helms C, Liu Y, Cornelius LA, Bowcock, AM.  Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients.  Exp Dermatol. 2009;18(5):485-7.

* Gardner JM, Evans KG, Musiek AC, Rook AH, Kim EJ. Update on the treatment of cutaneous T-cell lymphoma (CTCL).  Curr Opin Oncol. 2009;21(2):131-7.

Rapael BA, Shin DB, Suchin KR, Morrissey KA, Vittorio CC, Kim EJ, Gardner JM, Evans KG, Introcaso CE, Samimi SS, Gelfand JM, Rook AH.  High clinical response rate of Sezary Syndrome to immunomodulatory therapies: prognostic markers of response.  Arch Dermatol.  2011; 147 (12): 1410-5.


top of page